Literature DB >> 7591138

Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural, zoonotic cycle compared with maintenance in culture.

W T Golde1, M C Dolan.   

Abstract

The original isolate of Borrelia burgdorferi, strain B31, can be maintained in vitro indefinitely. A number of studies have demonstrated that there are recognizable changes in the genetic composition of the spirochete after more than 60 passages. We have maintained B31 in the natural zoonotic cycle of transmission of infection between laboratory mice and laboratory-reared Ixodes ticks. To determine whether similar changes occur in the natural transmission cycle, we reisolated strain B31 from mouse skin at the fifth zoonotic cycle. This reisolated derivative had the same infectivity as the parent B31 strain, had lost the 8-kb supercoiled plasmid present in B31, and induced a gross serum antibody response indistinguishable from the B31 immune response. Analysis of antigen expression with monoclonal antibodies generated against B31, however, showed differential expression of a subset of antigens between B31 and the isolated derivative.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591138      PMCID: PMC173687          DOI: 10.1128/iai.63.12.4795-4801.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.

Authors:  J Hinnebusch; A G Barbour
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

2.  Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi.

Authors:  W J Simpson; C F Garon; T G Schwan
Journal:  Microb Pathog       Date:  1990-02       Impact factor: 3.738

Review 3.  Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

4.  Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus.

Authors:  J Hinnebusch; A G Barbour
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

5.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

6.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice.

Authors:  T G Schwan; R H Karstens; M E Schrumpf; W J Simpson
Journal:  Can J Microbiol       Date:  1991-06       Impact factor: 2.419

8.  Ear punch biopsy method for detection and isolation of Borrelia burgdorferi from rodents.

Authors:  R J Sinsky; J Piesman
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

9.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi.

Authors:  W T Golde; T R Burkot; S Sviat; M G Keen; L W Mayer; B J Johnson; J Piesman
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  12 in total

1.  Culturing selects for specific genotypes of Borrelia burgdorferi in an enzootic cycle in Colorado.

Authors:  D E Norris; B J Johnson; J Piesman; G O Maupin; J L Clark; W C Black
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Multiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis.

Authors:  D S Guttman; P W Wang; I N Wang; E M Bosler; B J Luft; D E Dykhuizen
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice.

Authors:  G Wang; C Ojaimi; R Iyer; V Saksenberg; S A McClain; G P Wormser; I Schwartz
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto.

Authors:  W T Golde; B Robinson-Dunn; M G Stobierski; D Dykhuizen; I N Wang; V Carlson; H Stiefel; S Shiflett; G L Campbell
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

5.  Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates.

Authors:  Guiqing Wang; Radha Iyer; Susan Bittker; Denise Cooper; Jennifer Small; Gary P Wormser; Ira Schwartz
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1.

Authors:  M Labandeira-Rey; J T Skare
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Accelerated infectivity of tick-transmitted Lyme disease spirochetes to vector ticks.

Authors:  C M Shih; L P Liu
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

8.  Purification and characterization of Borrelia burgdorferi from feeding nymphal ticks (Ixodes scapularis).

Authors:  S Rathinavelu; A M de Silva
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level.

Authors:  Dorothee Grimm; Abdallah F Elias; Kit Tilly; Patricia A Rosa
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.

Authors:  Clayton O Jarrett; Florent Sebbane; Jeffrey J Adamovicz; Gerard P Andrews; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.